Reviewer ’s report  
 
Title: Psychometric properties of the Persian version of the celiac disease adherence test 
questionnaire  
 
Version: 0 Date: 02 Jul 2020  
Reviewer's report:  
Dear Sir  
I've read with great interest the manuscript by Nikniaz et al. entitled "Psychometric properties of 
the Persian version of the celiac d isease adherence test (CDAT) questionnaire". The manuscrict 
describes the feasibility of the CDTA questionnaire for celiac patients in the persian area  
Questionnaires are very important to monitor CD and this study represents a "step up" in the 
diffusion a  celiac disease "culture" in a large geographical area, and, from this point of view, it is 
absolutely wellcome  
 
I have only few minor concerns  
- Avoid abbreviation in the tile  
- In the abstract there are too many abbreviations  
- I think daniel leffler sh ould be acknowledged in the appropriate section  
- A paragraph describing other possible questionnaires for CD and why the authors used CDAT 
should be inserted in the Discussion  
- Questionnaires can be very important in the Covid era because they could be u sed to "tele -
monitor" patients; A comment about this issue may be inserted  
 
 
 
Publons Reviewer Recognition . Springer Nature can send verification of this review directly to  
Publons (a subsidiary of Clarivate Analytics). If you would like to take advantage of this service, 
please click on the “Yes” option below. Your name, email  address, title of the reviewed 
manuscript, name of the journal, and date of your review submission (the “Review Data ”) will 
then be tr ansmitted to Publons upon publication of the manuscript.  If you have already registered 
at Publons, they will notify you of the receipt of this review and update your profile as per your 
settings and their policy. If you are not registered with Publons, yo u will receive an email from 
them asking you to register in order for them to be able to re cognize your review on your new 
profile page. Publons may use the Review Data to generate derivat ive metadata for the benefit of 
Publons and you as a reviewer, caref ully considering the sensi tivity of such information. For 
example, Publons may verify your record as a reviewer by updating your profile published on its  
webservice if you have registered for such service or help editors to identify candidate reviewers.  
Please find the details of processing in Publons ’ privacy policy https://publons.com/about/terms  
 
Yes 
 
Are the methods appropriate and well described?  
If not, please specify what is required in your comments to the authors.  
 
Yes 
 
Does the work include the necessary controls?  
If not, please specify which controls are required in your comments to the authors.  
 
Yes 
 
Are the conclusions drawn adequately supported by the data shown?  
If not, please explain in your comments to the auth ors. 
 
Yes 
 
Are you able to assess any statistics in the manus cript or would you recommend an 
additional statistical review?  
If an additional statistical review is recommended, please specify what aspects require further  
assessment in your comments to the edi tors. 
 
I am able to assess the statistics  
 
Quality of written English  
Please indicate the quality of language in the manuscript:  
 
Acceptable  
 
Declaration of competing interests  
Please complete a declaration of compet ing interests, considering the following questions:  
 
1. Have you in the past five years received reimbursements, f ees, funding, or salary from an 
organisation that may in any way gain or lose financial ly from the publication of this 
manuscript, either now o r in the future?  
 
2. Do you hold any stocks or shares in an organisation t hat may in any way gain or lose 
financially from the publication of this manuscript, either now or in the future?  
 
3. Do you hold or are you currently applying for any patents relating  to the content of the 
manuscript?  
 
4. Have you received reimbursements, fees, funding, or salary from an organization that 
holds or has applied for patents relating to the content of the manuscript?  
 
5. Do you have any other financial competing interests?  
 
6. Do you have any non -financial competing interests in relation to this paper?  
 
If you can answer no to all of the above, write 'I declare that I have  no competing interests' 
below. If your reply is yes to any, please give details below.  
 
None 
 
Reviewer Publication Consent. I agree for my report to be made  available under an Open 
Access Creative Commons CC -BY License ( http://creativecommons.org/licenses/by/4.0 ) if this 
manuscript is accepted for publication. Any comments that I do not wish to be included in the 
published report have been included as confidential comments to the editor,  which will not be 
published.If you are not happy for us to publish this report, please contact the editorial office 
before completing the review.  If you wish, you can include your name in your publish ed report. 
Please note you must decide whether to include your name at the start of the process and  confirm 
this decision whenever prompted. If you change y our decision later, we will not be able to 
publish your name.  
 
I agree to the terms of the CC -BY 4.0 license; please do not publish my name with my report.  
(default)  
 
Reviewer ’s report  
 
Title: Psychometric properties of the Persian version of the celiac disease adherence test 
questionnaire  
 
Version: 0 Date: 02 Jul 2020  
Reviewer's report:  
Dear Sir  
I've read with great interest the manuscript by Nikniaz et al. entitled "Psychometric properties of 
the Persian version of the celiac d isease adherence test (CDAT) questionnaire". The manuscrict 
describes the feasibility of the CDTA questionnaire for celiac patients in the persian area  
Questionnaires are very important to monitor CD and this study represents a "step up" in the 
diffusion a  celiac disease "culture" in a large geographical area, and, from this point of view, it is 
absolutely wellcome  
 
I have only few minor concerns  
- Avoid abbreviation in the tile  
- In the abstract there are too many abbreviations  
- I think daniel leffler sh ould be acknowledged in the appropriate section  
- A paragraph describing other possible questionnaires for CD and why the authors used CDAT 
should be inserted in the Discussion  
- Questionnaires can be very important in the Covid era because they could be u sed to "tele -
monitor" patients; A comment about this issue may be inserted  
 
 
 
Publons Reviewer Recognition . Springer Nature can send verification of this review directly to  
Publons (a subsidiary of Clarivate Analytics). If you would like to take advantage of this service, 
please click on the “Yes” option below. Your name, email  address, title of the reviewed 
manuscript, name of the journal, and date of your review submission (the “Review Data ”) will 
then be tr ansmitted to Publons upon publication of the manuscript.  If you have already registered 
at Publons, they will notify you of the receipt of this review and update your profile as per your 
settings and their policy. If you are not registered with Publons, yo u will receive an email from 
them asking you to register in order for them to be able to re cognize your review on your new 
profile page. Publons may use the Review Data to generate derivat ive metadata for the benefit of 
Publons and you as a reviewer, caref ully considering the sensi tivity of such information. For 
example, Publons may verify your record as a reviewer by updating your profile published on its  
webservice if you have registered for such service or help editors to identify candidate reviewers.  
Please find the details of processing in Publons ’ privacy policy https://publons.com/about/terms  
 
Yes 
 
Are the methods appropriate and well described?  
If not, please specify what is required in your comments to the authors.  
 
Yes 
 
Does the work include the necessary controls?  
If not, please specify which controls are required in your comments to the authors.  
 
Yes 
 
Are the conclusions drawn adequately supported by the data shown?  
If not, please explain in your comments to the auth ors. 
 
Yes 
 
Are you able to assess any statistics in the manus cript or would you recommend an 
additional statistical review?  
If an additional statistical review is recommended, please specify what aspects require further  
assessment in your comments to the edi tors. 
 
I am able to assess the statistics  
 
Quality of written English  
Please indicate the quality of language in the manuscript:  
 
Acceptable  
 
Declaration of competing interests  
Please complete a declaration of compet ing interests, considering the following questions:  
 
1. Have you in the past five years received reimbursements, f ees, funding, or salary from an 
organisation that may in any way gain or lose financial ly from the publication of this 
manuscript, either now o r in the future?  
 
2. Do you hold any stocks or shares in an organisation t hat may in any way gain or lose 
financially from the publication of this manuscript, either now or in the future?  
 
3. Do you hold or are you currently applying for any patents relating  to the content of the 
manuscript?  
 
4. Have you received reimbursements, fees, funding, or salary from an organization that 
holds or has applied for patents relating to the content of the manuscript?  
 
5. Do you have any other financial competing interests?  
 
6. Do you have any non -financial competing interests in relation to this paper?  
 
If you can answer no to all of the above, write 'I declare that I have  no competing interests' 
below. If your reply is yes to any, please give details below.  
 
None 
 
Reviewer Publication Consent. I agree for my report to be made  available under an Open 
Access Creative Commons CC -BY License ( http://creativecommons.org/licenses/by/4.0 ) if this 
manuscript is accepted for publication. Any comments that I do not wish to be included in the 
published report have been included as confidential comments to the editor,  which will not be 
published.If you are not happy for us to publish this report, please contact the editorial office 
before completing the review.  If you wish, you can include your name in your publish ed report. 
Please note you must decide whether to include your name at the start of the process and  confirm 
this decision whenever prompted. If you change y our decision later, we will not be able to 
publish your name.  
 
I agree to the terms of the CC -BY 4.0 license; please do not publish my name with my report.  
(default)  
 
Please review this paper.
user
Reviewer ’s report  
 
Title: Psychometric properties of the Persian version of the celiac disease adherence test 
questionnaire  
 
Version: 0 Date: 02 Jul 2020  
Reviewer's report:  
Dear Sir  
I've read with great interest the manuscript by Nikniaz et al. entitled "Psychometric properties of 
the Persian version of the celiac d isease adherence test (CDAT) questionnaire". The manuscrict 
describes the feasibility of the CDTA questionnaire for celiac patients in the persian area  
Questionnaires are very important to monitor CD and this study represents a "step up" in the 
diffusion a  celiac disease "culture" in a large geographical area, and, from this point of view, it is 
absolutely wellcome  
 
I have only few minor concerns  
- Avoid abbreviation in the tile  
- In the abstract there are too many abbreviations  
- I think daniel leffler sh ould be acknowledged in the appropriate section  
- A paragraph describing other possible questionnaires for CD and why the authors used CDAT 
should be inserted in the Discussion  
- Questionnaires can be very important in the Covid era because they could be u sed to "tele -
monitor" patients; A comment about this issue may be inserted  
 
 
 
Publons Reviewer Recognition . Springer Nature can send verification of this review directly to  
Publons (a subsidiary of Clarivate Analytics). If you would like to take advantage of this service, 
please click on the “Yes” option below. Your name, email  address, title of the reviewed 
manuscript, name of the journal, and date of your review submission (the “Review Data ”) will 
then be tr ansmitted to Publons upon publication of the manuscript.  If you have already registered 
at Publons, they will notify you of the receipt of this review and update your profile as per your 
settings and their policy. If you are not registered with Publons, yo u will receive an email from 
them asking you to register in order for them to be able to re cognize your review on your new 
profile page. Publons may use the Review Data to generate derivat ive metadata for the benefit of 
Publons and you as a reviewer, caref ully considering the sensi tivity of such information. For 
example, Publons may verify your record as a reviewer by updating your profile published on its  
webservice if you have registered for such service or help editors to identify candidate reviewers.  
Please find the details of processing in Publons ’ privacy policy https://publons.com/about/terms  
 
Yes 
 
Are the methods appropriate and well described?  
If not, please specify what is required in your comments to the authors.  
 
Yes 
 
Does the work include the necessary controls?  
If not, please specify which controls are required in your comments to the authors.  
 
Yes 
 
Are the conclusions drawn adequately supported by the data shown?  
If not, please explain in your comments to the auth ors. 
 
Yes 
 
Are you able to assess any statistics in the manus cript or would you recommend an 
additional statistical review?  
If an additional statistical review is recommended, please specify what aspects require further  
assessment in your comments to the edi tors. 
 
I am able to assess the statistics  
 
Quality of written English  
Please indicate the quality of language in the manuscript:  
 
Acceptable  
 
Declaration of competing interests  
Please complete a declaration of compet ing interests, considering the following questions:  
 
1. Have you in the past five years received reimbursements, f ees, funding, or salary from an 
organisation that may in any way gain or lose financial ly from the publication of this 
manuscript, either now o r in the future?  
 
2. Do you hold any stocks or shares in an organisation t hat may in any way gain or lose 
financially from the publication of this manuscript, either now or in the future?  
 
3. Do you hold or are you currently applying for any patents relating  to the content of the 
manuscript?  
 
4. Have you received reimbursements, fees, funding, or salary from an organization that 
holds or has applied for patents relating to the content of the manuscript?  
 
5. Do you have any other financial competing interests?  
 
6. Do you have any non -financial competing interests in relation to this paper?  
 
If you can answer no to all of the above, write 'I declare that I have  no competing interests' 
below. If your reply is yes to any, please give details below.  
 
None 
 
Reviewer Publication Consent. I agree for my report to be made  available under an Open 
Access Creative Commons CC -BY License ( http://creativecommons.org/licenses/by/4.0 ) if this 
manuscript is accepted for publication. Any comments that I do not wish to be included in the 
published report have been included as confidential comments to the editor,  which will not be 
published.If you are not happy for us to publish this report, please contact the editorial office 
before completing the review.  If you wish, you can include your name in your publish ed report. 
Please note you must decide whether to include your name at the start of the process and  confirm 
this decision whenever prompted. If you change y our decision later, we will not be able to 
publish your name.  
 
I agree to the terms of the CC -BY 4.0 license; please do not publish my name with my report.  
(default)  
 
assistant